John Sundy

Director/Board Member at SANOFI

62 year

Consumer Services

Health Technology

Profile

John Sundy is currently an Independent Director at Sanofi and a Director at Neutrolis, Inc. Previously, he held the position of Senior Vice President at Gilead Sciences, Inc. from 2014 to 2020.
He also served as an Associate Professor at Duke University and Duke-NUS Graduate Medical School Singapore from 2006 to 2014.
Additionally, he was the Chief Medical Officer at Pandion Therapeutics, Inc. Dr. Sundy completed his undergraduate degree at Bucknell University and obtained doctorate degrees from Drexel University College of Medicine and Hahnemann University.

John Sundy active positions

Companies	Position	Start
SANOFI	Director/Board Member	29/04/2024
Neutrolis, Inc. Neutrolis, Inc. Pharmaceuticals: MajorHealth Technology Neutrolis, Inc. is a biotechnology company located in North Cambridge, MA. The company develops first-in-class therapies that target neutrophils and their pathogenic products, including nets. Neutrolis proprietary platform, Chromatinase™, is based on the naturally occurring enzymes that break down the extracellular chromatin that form nets. The company's lead product, NTR-441, is a patented, first-in-class, engineered DNASE1L3 analog with potential application in COVID-19, ARDS, lupus, rheumatoid arthritis, systemic sclerosis, and other net-mediated diseases. Neutrolis has received two competitive LabCentral Golden Ticket awards from Pfizer and Bristol-Myers Squibb. The company was founded by Abdul Hakkim and Toby Fox. Toby Fox has been the CEO since incorporation.	Director/Board Member	-

All active positions of John Sundy

Former positions of John Sundy

Companies	Position	End
GILEAD SCIENCES, INC.	Corporate Officer/Principal	31/03/2020
Duke University Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC.	Corporate Officer/Principal	31/12/2013
Duke-NUS Graduate Medical School Singapore	Corporate Officer/Principal	31/12/2013
PANDION THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	-

See the detail of John Sundy's experience

Training of John Sundy

Bucknell University	Undergraduate Degree
Hahnemann University	Doctorate Degree
Drexel University College of Medicine	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of John Sundy's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
GILEAD SCIENCES, INC.	Health Technology
SANOFI	Health Technology

Private companies	2
Pandion Therapeutics, Inc. Pandion Therapeutics, Inc. BiotechnologyHealth Technology Pandion Therapeutics, Inc. is a clinical stage biopharmaceutical company. It develops Therapeutic Autoimmune reguLatOry proteiN (TALON) drug design and discovery platform, which employ a modular approach to create a pipeline of product candidates using immunomodulatory effector modules that act at known control nodes within the immune network. The company was founded by Dr. Joanne Viney on September 19, 2016 and is headquartered in Watertown, MA.	Health Technology
Neutrolis, Inc. Neutrolis, Inc. Pharmaceuticals: MajorHealth Technology Neutrolis, Inc. is a biotechnology company located in North Cambridge, MA. The company develops first-in-class therapies that target neutrophils and their pathogenic products, including nets. Neutrolis proprietary platform, Chromatinase™, is based on the naturally occurring enzymes that break down the extracellular chromatin that form nets. The company's lead product, NTR-441, is a patented, first-in-class, engineered DNASE1L3 analog with potential application in COVID-19, ARDS, lupus, rheumatoid arthritis, systemic sclerosis, and other net-mediated diseases. Neutrolis has received two competitive LabCentral Golden Ticket awards from Pfizer and Bristol-Myers Squibb. The company was founded by Abdul Hakkim and Toby Fox. Toby Fox has been the CEO since incorporation.	Health Technology